• Exchange: OTC US
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Generic Pharma

Hikma Pharmaceuticals PLC

+ Add to Watchlist


27.3000 USD 0.9389 3.32%

As of 20:10:00 ET on 09/09/2014.

Snapshot for Hikma Pharmaceuticals PLC (HKMPF)

Open: 27.3000 Day's Range: 27.3000 - 27.3000 Volume: 181
Previous Close: 28.2389 52wk Range: 16.4025 - 28.9204 1-Yr Rtn: -

Stock Chart for HKMPF

No chart data available.
  • HKMPF:US 27.3000
  • 1D
  • 1M
  • 1Y
Interactive HKMPF Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for HKMPF

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) 20.4955
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) 1.3320
Est. PEG Ratio 0.9367
Market Cap (M USD) 5,419.75
Shares Outstanding (M) 198.53
30 Day Average Volume 75
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield 0.81%
Cash Dividend (USD) 0.0700
Dividend Ex-Date 08/27/2014
5 Year Dividend Growth 26.93%
Next Earnings Announcement 03/12/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for HKMPF

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for HKMPF

Hikma Pharmaceuticals PLC is a multinational pharmaceutical group focused on developing, manufacturing, and marketing a range of both branded and non-branded generic and in-licensed pharmaceutical products. The Company's operations are conducted in the United States, the Middle East, and North Africa region, as well as Europe.

Mazen Samih Taleb DarwazahVice Chairman/CEO:MENASaid Sameeh Talib DarwazahChief Executive Officer
Michael Raya "Mike"President & CEO:USKhalid NabilsiChief Financial Officer
More Company Profile & Key Executives for HKMPF

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil